Full Text
HPR47 Does Orphan Drug Designation Lead to Reimbursement in EU5?

Abstract

Authors

V Huertas Carrera M Malmenas S Koné Guissou

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×